Geen aandoening
Conditions
Interventions
Clonidine results in less noradrenaline turnover and in effect inhibits the
noradrenergic system.
Each participants receives all conditions, 1x clonidine, and 1x placebo, spread
across two days.
Sponsors
Universiteit Utrecht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Passing the physical/medical evaluation (in which cardiovascular functioning and blood pressure is evaluated) is a prerequisite.
Exclusion criteria
Exclusion criteria: Diagnosis of psychopathology. Current drug use Low blood pressure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Behavioural measures In the VSC paradigm: the validity effect in ms (RT valid cued target - RT invalid cued target). A larger validity effect reflects either more bias, or less disengagement. In the stop task paradigm: the stop signal reaction time (SSRT); SSRT reflects inhibition and related disengagement. Neurophysiological (Event Related Potentials, task related brain activity) endparameters in the VSC: 1) Parietal cue Event Related Potential (ERP) components. These are the Anterior Directing Attention Negativity (ADAN) and the Late Directing Attention Positivity (LDAP). Both are related to bias. 2) P1 ERP (following a validly cued target); associated with bias. 3) Late Positive Deflection (LPD) ERP (following an invalidly cued target); associated with disengagement. Neurophysiological (ERP) endparameters in the stop task: 1) N2 ERP (following the onset of a stopsignal), associated with disengagement. 2) LPD ERP (following the onset of a stopsignal), associated with disengagement. | — |
Countries
Netherlands
Outcome results
None listed